LAUSR

It is not disputable that chronic obstructive pulmonary disease (COPD) is a multifaceted disease affecting patients’ health beyond the lungs with immense variability between individuals [1–3]. Given that complexity and variability, multidimensional assessment and treatment integrating concepts of complex adaptive systems are needed [4]. Agusti and MacNee [5] stated that physicians need a “control panel” including at least three dimensions (severity, activity and impact) to assess different elements of the disease. This “control panel” might be useful for routine clinical practice and to move COPD management towards personalised medicine [5]. However, can one “control panel” reflect the complexity and heterogeneity of this complex, multisystem disease? Can one tool guarantee a personalised approach? Multidimensionality should be assessed by studying multi-dimensions, not by using a multidimensional assessment tool http://ow.ly/ht1c3091F29